UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally
- Status
- COMPLETED
- Phase
- PHASE2
Study of Combination PS-341 and Thalidomide in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Aprepitant (MK-0869) for Chemotherapy-Induced Nausea and Vomiting (CINV) in Adolescent Participants (MK-0869-097)
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)
- Status
- COMPLETED
- Phase
- PHASE3
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE2
S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2